Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$42.57 USD
+1.09 (2.63%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $42.53 -0.04 (-0.09%) 6:50 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 401 - 420 ( 441 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company to Acquire Amylin Pharmaceuticals, Expand Partnership with AstraZeneca
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
First Quarter Results in Line with Expectations
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Specialty Pharmaceuticals Short Interest Analysis
Provider: AURIGA USA
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Fourth Quarter Revenue Moved Up 7% With No Currency Tailwind
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of January 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Solid Performance from Existing Products with More on the Way
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES -The Week Ahead in Life Sciences - Upcoming Events for the Week of September 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
New Products and Currency Contribute to Mid- Teens Second Quarter Sales Growth.
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S